drugset / Trial / NCT03840811

Experimental Human Infection With Neisseria Gonorrhoeae

NCT03840811

Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a Phase 1, interventional, non-randomized, experimental infection model study with healthy adult males adults (N=32) between the ages of 18-36 at study enrollment. The study is designed to test the requirements of predicted N. gonorrhoeae virulence determinants for gonococcal infection in the male urethra. The duration for all participants will be about 3 weeks. Study duration will be approximately about 18 months for implementation and enrollment. The primary objectives of the present study are to: (1) compare infectivity of different isogenic mutants with wild-type (WT) N. gonorrhoeae in noncompetitive infections and to (2) assess relative fitness of the mutant in competitive infections initiated by inocula containing equivalent numbers of both WT and mutant strains for mutants with WT infectivity.

Timeline

Start
2017-04-23
Primary completion
2019-11-25
Completion
2019-11-25

Drugs

EvaluationDrugModalityDoseRoute
Background Cefixime Other / unclassified 400 mg
Background Ceftriaxone Other / unclassified 250 mg Intramuscular
Background Ciprofloxacin Small molecule 500 mg Oral

Indications